Medicure (OTCMKTS:MCUJF) Announces Quarterly Earnings Results

Medicure (OTCMKTS:MCUJF) announced its earnings results on Wednesday. The company reported ($0.09) earnings per share (EPS) for the quarter, Zacks reports. Medicure had a negative net margin of 5.70% and a negative return on equity of 6.65%.

Medicure Stock Up 3.8%

Shares of OTCMKTS:MCUJF traded up $0.03 during midday trading on Wednesday, reaching $0.95. The company had a trading volume of 13,620 shares, compared to its average volume of 3,274. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.48 and a quick ratio of 1.06. The stock’s fifty day moving average price is $0.81 and its 200-day moving average price is $0.81. The stock has a market capitalization of $9.94 million, a P/E ratio of -9.52 and a beta of 1.04. Medicure has a one year low of $0.44 and a one year high of $0.96.

About Medicure

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.